Emery‐Dreifuss muscular dystrophy
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Emery‐Dreifuss muscular dystrophy (EDMD) is a rare muscular dystrophy, but is particularly important to diagnose due to frequent life‐threatening cardiac complications. EDMD classically presents with muscle weakness, early contractures, cardiac conduction abnormalities and cardiomyopathy, although the presence and severity of these manifestations vary by subtype and individual. Associated genes include EMD, LMNA, SYNE1, SYNE2, FHL1, TMEM43, SUN1, SUN2, and TTN, encoding emerin, lamin A/C, nesprin‐1, nesprin‐2, FHL1, LUMA, SUN1, SUN2, and titin, respectively. The Online Mendelian Inheritance in Man database recognizes subtypes 1 through 7, which captures most but not all of the associated genes. Genetic diagnosis is essential whenever available, but traditional diagnostic tools can help steer the evaluation toward EDMD and assist with interpretation of equivocal genetic test results. Management is primarily supportive, but it is important to monitor patients closely, especially for potential cardiac complications. There is a high potential for progress in the treatment of EDMD in the coming years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546
Prevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome
Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., Erdos, M. R., Robbins, C. M., Moses, T. Y., Berglund, P., et al. (2003) · Nature · doi:10.1038/nature01629 · Cited by 1,990 · cited 1×
“These alternate phenotypes include a congenital muscular dystrophy with a distinct “dropped head” syndrome caused by severe neck muscle weakness,(80) autosomal dominant dilated cardiomyopathy with conduction defect,(81) familial partial lipodystrophy (FPLD),(82,83) an autosomal recessive axonal Charcot– Marie-Tooth (C…”
BackgroundEpstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e318276ce9b · Cited by 1,489
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485 · cited 1×
“Mutations in TTN have been associated with various phenotypes, including distal tibial myopathy, limb-girdle muscular dystrophy (LGMD R10 titin-related, previously known as LGMD2J),(44,45) and dilated cardiomyopathy.(46,47) Recent reports indicate that the EDMD phenotype is also associated with TTN mutations, includin…”
BackgroundFatkin, D., MacRae, C., Sasaki, T., Wolff, M. R., Porcu, M., Frenneaux, M., Atherton, J., Vidaillet, H. J., Spudich, S., De Girolami, U., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412302 · Cited by 1,359
Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
Bonne, G., Barletta, M. R. D., Varnous, S., Bécane, H.-M., Hammouda, E.-H., Merlini, L., Muntoni, F., Greenberg, C. R., Gary, F., Urtizberea, J.-A., et al. (1999) · Nature Genetics · doi:10.1038/6799 · Cited by 1,358 · cited 4×
“Autosomal recessive mutations in LMNA have also been associated with EDMD, and these have been assigned to the subtype EDMD3.(10,18,32,33)”
BackgroundMethodInfluentialLoss of a-Type Lamin Expression Compromises Nuclear Envelope Integrity Leading to Muscular Dystrophy
Sullivan, T., Escalante-Alcalde, D., Bhatt, H., Anver, M., Bhat, N., Nagashima, K., Stewart, C. L., & Burke, B. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.5.913 · Cited by 1,211
Dechat, T., Pfleghaar, K., Sengupta, K., Shimi, T., Shumaker, D. K., Solimando, L., & Goldman, R. D. (2008) · Genes & Development · doi:10.1101/gad.1652708 · Cited by 940
Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy
Bione, S., Maestrini, E., Rivella, S., Mancini, M., Regis, S., Romeo, G., & Toniolo, D. (1994) · Nature Genetics · doi:10.1038/ng1294-323 · Cited by 888 · cited 5×
“The gene was subsequently cloned and assigned the symbol EMD.(17,26,27) The encoded protein, emerin, is a 254 amino acid”
BackgroundMethodInfluentialTracy, C. M., Epstein, A. E., Darbar, D., DiMarco, J. P., Dunbar, S. B., Estes, N. A. M., Ferguson, T. B., Hammill, S. C., Karasik, P. E., Link, M. S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.007 · Cited by 732
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
Shackleton, S., Lloyd, D. J., Jackson, S. N. J., Evans, R., Niermeijer, M. F., Singh, B. M., Schmidt, H., Brabant, G., Kumar, S., Durrington, P. N., et al. (2000) · Nature Genetics · doi:10.1038/72807 · Cited by 704
Cao, H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.1.109 · Cited by 662
Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy
Gerull, B., Gramlich, M., Atherton, J., McNabb, M., Trombitás, K., Sasse-Klaassen, S., Seidman, J. G., Seidman, C., Granzier, H., Labeit, S., et al. (2002) · Nature Genetics · doi:10.1038/ng815 · Cited by 616 · cited 1×
“Mutations in TTN have been associated with various phenotypes, including distal tibial myopathy, limb-girdle muscular dystrophy (LGMD R10 titin-related, previously known as LGMD2J),(44,45) and dilated cardiomyopathy.(46,47) Recent reports indicate that the EDMD phenotype is also associated with TTN mutations, includin…”
BackgroundMuchir, A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1453 · Cited by 616 · cited 1×
“Of note, a subtype of autosomal dominant LGMD, LGMD1B, was previously associated with LMNA mutations.(87) However, a recent reclassification of the LGMDs recognizes laminopathy as a separate category of muscle disease.”
BackgroundInteractions Between Nuclei and the Cytoskeleton Are Mediated by SUN-KASH Nuclear-Envelope Bridges
Starr, D. A., & Fridolfsson, H. N. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100109-104037 · Cited by 581
De Sandre-Giovannoli, A., Chaouch, M., Kozlov, S., Vallat, J.-M., Tazir, M., Kassouri, N., Szepetowski, P., Hammadouche, T., Vandenberghe, A., Stewart, C. L., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339274 · Cited by 565
Norwood, F. L. M., Harling, C., Chinnery, P. F., Eagle, M., Bushby, K., & Straub, V. (2009) · Brain · doi:10.1093/brain/awp236 · Cited by 541
Zhang, Q., Bethmann, C., Worth, N. F., Davies, J. D., Wasner, C., Feuer, A., Ragnauth, C. D., Yi, Q., Mellad, J. A., Warren, D. T., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm238 · Cited by 539 · cited 2×
“when the synaptic nuclear envelope genes SYNE1 and SYNE2, encoding Nesprin-1 and Nesprin-2, respectively, were found to be associated with EDMD and subsequently assigned to the respective subtypes EDMD4 and EDMD5.(23) Nesprins contribute to nuclear envelope localization and structural integrity.”
BackgroundHuman laminopathies: nuclei gone genetically awry
Capell, B. C., & Collins, F. S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1906 · Cited by 527
Hackman, P., Vihola, A., Haravuori, H., Marchand, S., Sarparanta, J., de Seze, J., Labeit, S., Witt, C., Peltonen, L., Richard, I., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342380 · Cited by 473
van Berlo, J. H., de Voogt, W. G., van der Kooi, A. J., van Tintelen, J. P., Bonne, G., Yaou, R. B., Duboc, D., Rossenbacker, T., Heidbüchel, H., de Visser, M., et al. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0589-1 · Cited by 472
Raffaele di Barletta, M., Ricci, E., Galluzzi, G., Tonali, P., Mora, M., Morandi, L., Romorini, A., Voit, T., Orstavik, K. H., Merlini, L., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302869 · Cited by 415
Long-Term Outcome and Risk Stratification in Dilated Cardiolaminopathies
Pasotti, M., Klersy, C., Pilotto, A., Marziliano, N., Rapezzi, C., Serio, A., Mannarino, S., Gambarin, F., Favalli, V., Grasso, M., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.06.044 · Cited by 404 · cited 1×
“For LMNA mutations in particular, the high penetrance, especially with regard to cardiac symptoms (nearly complete by the age of 60 years), and potential severity (initial manifestation can be sudden cardiac death [SCD]) must be appreciated; therefore, everyone who harbors these mutations requires a comprehensive card…”
BackgroundUnusual type of benign x-linked muscular dystrophy.
Emery, A. E., & Dreifuss, F. E. (1966) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.29.4.338 · Cited by 399 · cited 2×
“Hypertrophy of the quadriceps and extensor digitorum brevis musculature has also been reported in EDMD2, but not in EDMD1; this appears to be true hypertrophy rather than pseudohypertrophy as connective tissue infiltration is not prominent on muscle biopsy.(3,10) In EDMD1, skeletal muscle symptoms usually occur before…”
BackgroundStraub, V. W., Murphy, A. P., Udd, B., Angelini, C. I., Aymé, S., Bönnemann, C. G., de Visser, M., Hamosh, A., Jacobs, L., Khizanishvili, N., et al. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2018.05.007 · Cited by 385
Nuclear Mechanics and Mechanotransduction in Health and Disease
Isermann, P., & Lammerding, J. (2013) · Current Biology · doi:10.1016/j.cub.2013.11.009 · Cited by 384
Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells
Lammerding, J., Hsiao, J., Schulze, P. C., Kozlov, S., Stewart, C. L., & Lee, R. T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200502148 · Cited by 381
The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein
Manilal, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.6.801 · Cited by 380 · cited 2×
“In EDMD1, for example, the anti-emerin antibody shows absence of staining of the inner nuclear membrane.(27,28) This finding can be seen not only in muscle, but also in peripheral leukocytes, skin fibroblasts, and buccal cells.”
BackgroundPrimary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations
Meune, C., Van Berlo, J. H., Anselme, F., Bonne, G., Pinto, Y. M., & Duboc, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmc052632 · Cited by 369 · cited 1×
“cardioverter defibrillator (ICD) concurrently with a pacemaker in the setting of LMNA mutations due to the high risk of fatal tachyarrhythmias.(15,127,128) Another source recommends ICD placement as soon as ventricular tachycardia is detected.”
BackgroundA progeroid syndrome in mice is caused by defects in A-type lamins
Mounkes, L. C., Kozlov, S., Hernandez, L., Sullivan, T., & Stewart, C. L. (2003) · Nature · doi:10.1038/nature01631 · Cited by 367 · cited 1×
“These alternate phenotypes include a congenital muscular dystrophy with a distinct “dropped head” syndrome caused by severe neck muscle weakness,(80) autosomal dominant dilated cardiomyopathy with conduction defect,(81) familial partial lipodystrophy (FPLD),(82,83) an autosomal recessive axonal Charcot– Marie-Tooth (C…”
BackgroundEmerin deficiency at the nuclear membrane in patients with Emery-Dreif uss muscular dystrophy
Nagano, A., Koga, R., Ogawa, M., Kurano, Y., Kawada, J., Okada, R., Hayashi, Y. K., Tsukahara, T., & Arahata, K. (1996) · Nature Genetics · doi:10.1038/ng0396-254 · Cited by 341
Arimura, T., Helbling-Leclerc, A., Massart, C., Varnous, S., Niel, F., Lacène, E., Fromes, Y., Toussaint, M., Mura, A.-M., Keller, D. I., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi017 · Cited by 330
Brodsky, G. L., Muntoni, F., Miocic, S., Sinagra, G., Sewry, C., & Mestroni, L. (2000) · Circulation · doi:10.1161/01.cir.101.5.473 · Cited by 330
Muchir, A., Pavlidis, P., Decostre, V., Herron, A. J., Arimura, T., Bonne, G., & Worman, H. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29042 · Cited by 309
Feingold, B., Mahle, W. T., Auerbach, S., Clemens, P., Domenighetti, A. A., Jefferies, J. L., Judge, D. P., Lal, A. K., Markham, L. W., Parks, W. J., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000526 · Cited by 306
De novo LMNA mutations cause a new form of congenital muscular dystrophy
Quijano‐Roy, S., Mbieleu, B., Bönnemann, C. G., Jeannet, P., Colomer, J., Clarke, N. F., Cuisset, J., Roper, H., De Meirleir, L., D'Amico, A., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21417 · Cited by 298
Haque, F., Mazzeo, D., Patel, J. T., Smallwood, D. T., Ellis, J. A., Shanahan, C. M., & Shackleton, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071910 · Cited by 287
Zhang, Q., Ragnauth, C. D., Skepper, J. N., Worth, N. F., Warren, D. T., Roberts, R. G., Weissberg, P. L., Ellis, J. A., & Shanahan, C. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.01642 · Cited by 277
Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation
Frock, R. L., Kudlow, B. A., Evans, A. M., Jameson, S. A., Hauschka, S. D., & Kennedy, B. K. (2006) · Genes & Development · doi:10.1101/gad.1364906 · Cited by 261
Nesprin‐1α self‐associates and binds directly to emerin and lamin A in vitro
Mislow, J. M. K., Holaska, J. M., Kim, M. S., Lee, K. K., Segura-Totten, M., Wilson, K. L., & McNally, E. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03105-8 · Cited by 260
BÉCANE, H., BONNE, G., VARNOUS, S., MUCHIR, A., ORTEGA, V., HAMMOUDA, E. H., URTIZBEREA, J., LAVERGNE, T., FARDEAU, M., EYMARD, B., et al. (2000) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2000.01661.x · Cited by 257
Mechanical Properties of the Cell Nucleus and the Effect of Emerin Deficiency
Rowat, A. C., Lammerding, J., & Ipsen, J. H. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.086454 · Cited by 254
Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation
Zhang, X., Xu, R., Zhu, B., Yang, X., Ding, X., Duan, S., Xu, T., Zhuang, Y., & Han, M. (2007) · Development · doi:10.1242/dev.02783 · Cited by 254 · cited 2×
“The clinical phenotypes related to SYNE1 or SYNE2 mutations can be quite variable, ranging from nearly asymptomatic hyperCKemia to a muscular dystrophy with severe DCM requiring heart transplantation.(37) Within this spectrum, most patients with EDMD4, associated with SYNE1 mutations, manifest with gradually progressi…”
BackgroundWilson, K. L., & Foisner, R. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000554 · Cited by 252
Direct Interaction between Emerin and Lamin A
Clements, L., Manilal, S., Love, D. R., & Morris, G. E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.2023 · Cited by 248
Markiewicz, E., Tilgner, K., Barker, N., van de Wetering, M., Clevers, H., Dorobek, M., Hausmanowa‐Petrusewicz, I., Ramaekers, F. C., Broers, J. L., Blankesteijn, W. M., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601230 · Cited by 246
Mutations of the FHL1 Gene Cause Emery-Dreifuss Muscular Dystrophy
Gueneau, L., Bertrand, A. T., Jais, J.-P., Salih, M. A., Stojkovic, T., Wehnert, M., Hoeltzenbein, M., Spuler, S., Saitoh, S., Verschueren, A., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.07.015 · Cited by 241 · cited 2×
“Female carriers may have cardiac defects, either in isolation or along with mild skeletal muscle involvement.(12,20,76) Mutations in FHL1 have also been associated with other myopathies, including reducing body myopathy, scapuloperoneal”
BackgroundRaharjo, W. H., Enarson, P., Sullivan, T., Stewart, C. L., & Burke, B. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.24.4447 · Cited by 230
Chen, C.-Y., Chi, Y.-H., Mutalif, R. A., Starost, M. F., Myers, T. G., Anderson, S. A., Stewart, C. L., & Jeang, K.-T. (2012) · Cell · doi:10.1016/j.cell.2012.01.059 · Cited by 228
Melcon, G., Kozlov, S., Cutler, D. A., Sullivan, T., Hernandez, L., Zhao, P., Mitchell, S., Nader, G., Bakay, M., Rottman, J. N., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi479 · Cited by 220 · cited 1×
“of a robust mouse model for laminopathy(134); in contrast, a mouse model that was developed for emerin deficiency has a more subtle phenotype.(135) For laminopathies, several preclinical studies have shown promising results, some focusing primarily on the cardiac phenotype.”
BackgroundVerhaert, D., Richards, K., Rafael-Fortney, J. A., & Raman, S. V. (2011) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.110.960740 · Cited by 218
Eine neue x-chromosomale Muskeldystrophie
Becker, P. E., & Kiener, F. (1955) · Archiv f�r Psychiatrie und Nervenkrankheiten Vereinigt mit Zeitschrift f�r die Gesamte Neurologie und Psychiatrie · doi:10.1007/bf00343141 · Cited by 217
Temsirolimus Activates Autophagy and Ameliorates Cardiomyopathy Caused by Lamin A/C Gene Mutation
Choi, J. C., Muchir, A., Wu, W., Iwata, S., Homma, S., Morrow, J. P., & Worman, H. J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003875 · Cited by 216 · cited 1×
“rapamycin (mTOR) pathway, which also appears to be involved in the pathogenesis of laminopathies.(142) Alleviation of oxidative stress in laminopathies has been achieved with N-acetyl cysteine.”
BackgroundA Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies
Mah, J. K., Korngut, L., Fiest, K. M., Dykeman, J., Day, L. J., Pringsheim, T., & Jette, N. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2015.311 · Cited by 208
Recessive TTN truncating mutations define novel forms of core myopathy with heart disease
Chauveau, C., Bonnemann, C. G., Julien, C., Kho, A. L., Marks, H., Talim, B., Maury, P., Arne-Bes, M. C., Uro-Coste, E., Alexandrovich, A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt494 · Cited by 191 · cited 2×
“Recent reports indicate that the EDMD phenotype is also associated with TTN mutations, including recessive truncating mutations.(19,48) Some of these patients have been reported to have cardiomyopathy,(48) while others have not.”
BackgroundGenetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients
Nallamilli, B. R. R., Chakravorty, S., Kesari, A., Tanner, A., Ankala, A., Schneider, T., da Silva, C., Beadling, R., Alexander, J. J., Askree, S. H., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.649 · Cited by 180
Meinke, P., Mattioli, E., Haque, F., Antoku, S., Columbaro, M., Straatman, K. R., Worman, H. J., Gundersen, G. G., Lattanzi, G., Wehnert, M., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004605 · Cited by 177 · cited 5×
“Such proteins include emerin, LMNA, nesprin-1, nesprin-2, LUMA, SUN1, and SUN2, which are encoded by the EMD, LMNA, SYNE1, SYNE2, TMEM43, SUN1, and SUN2 genes, respectively.17,18,20-23,43,52-66 Specifically, the linker of nucleoskeleton-and-cytoskeleton (LINC) bridging complex located at the nuclear envelope is believ…”
BackgroundMethodInfluentialBoriani, G., Gallina, M., Merlini, L., Bonne, G., Toniolo, D., Amati, S., Biffi, M., Martignani, C., Frabetti, L., Bonvicini, M., et al. (2003) · Stroke · doi:10.1161/01.str.0000064322.47667.49 · Cited by 177
Muchir, A., Shan, J., Bonne, G., Lehnart, S. E., & Worman, H. J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn343 · Cited by 176
Secondary calpain3 deficiency in 2q-linked muscular dystrophy: Titin is the candidate gene
Haravuori, H., Vihola, A., Straub, V., Auranen, M., Richard, I., Marchand, S., Voit, T., Labeit, S., Somer, H., Peltonen, L., et al. (2001) · Neurology · doi:10.1212/wnl.56.7.869 · Cited by 174
Muchir, A., Wu, W. E., Choi, J. C., Iwata, S., Morrow, J., Homma, S., & Worman, H. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds265 · Cited by 174
Emery‐dreifuss muscular dystrophy
Rowland, L. P., Fetell, M., Olarte, M., Hays, A., Singh, N., & Wanat, F. E. (1979) · Annals of Neurology · doi:10.1002/ana.410050203 · Cited by 171
A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield
Ankala, A., da Silva, C., Gualandi, F., Ferlini, A., Bean, L. J. H., Collins, C., Tanner, A. K., & Hegde, M. R. (2015) · Annals of Neurology · doi:10.1002/ana.24303 · Cited by 167 · cited 1×
“slightly larger mutations such as exon-level deletions, the sequencing panel is often supplemented by specific deletion-duplication testing as well.(115) The older Sanger sequencing technology is currently used only for selected applications such as verification of a specific single”
MethodTreating pediatric neuromuscular disorders: The future is now
Dowling, J. J., Gonorazky, H. D., Cohn, R. D., & Campbell, C. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38418 · Cited by 165 · cited 2×
“strategies that have a possible role in EDMD, such as adenoassociated virus (AAV)-based gene replacement and gene-editing techniques, have not been formally studied in this disease thus far.(146)”
BackgroundGarg, A., Speckman, R. A., & Bowcock, A. M. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01070-7 · Cited by 157
Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy
van der Kooi, A. J., Bonne, G., Eymard, B., Duboc, D., Talim, B., van der Valk, M., Reiss, P., Richard, P., Demay, L., Merlini, L., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.620 · Cited by 147
McGrath, M. J., Cottle, D. L., Nguyen, M.-A. T., Dyson, J. M., Coghill, I. D., Robinson, P. A., Holdsworth, M., Cowling, B. S., Hardeman, E. C., Mitchell, C. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512552200 · Cited by 145 · cited 2×
“An exception is FHL1, a protein encoded by the gene of the same name, which localizes to the sarcomere and the sarcolemma; at the former, it contributes to sarcomere assembly.(38,39) Mutant forms of emerin show diminished transport to the inner nuclear membrane,(68) and have been associated with decreased nuclear inva…”
BackgroundMutations in Emery-Dreifuss muscular dystrophy and their effects on emerin protein expression
Manilal, S. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.855 · Cited by 133 · cited 1×
“female carriers, emerin protein levels are variable, ranging from <5% of normal to normal levels.(111) Immunohistochemistry is not as useful in EDMD2, as staining for LMNA is normal in these patients.”
BackgroundCardiac features of Emery–Dreifuss muscular dystrophy caused by lamin A/C gene mutations
Sanna, T., Russo, A. D., Toniolo, D., Vytopil, M., Pelargonio, G., Martino, G. D., Ricci, E., Silvestri, G., Giglio, V., Messano, L., et al. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.020 · Cited by 132
TMEM43 mutations in emery‐dreifuss muscular dystrophy‐related myopathy
Liang, W., Mitsuhashi, H., Keduka, E., Nonaka, I., Noguchi, S., Nishino, I., & Hayashi, Y. K. (2010) · Annals of Neurology · doi:10.1002/ana.22338 · Cited by 129 · cited 10×
“Abnormally shaped nuclei can be seen as well.(21) However, these structural findings are not specific to EDMD, and thus”
BackgroundInfluentialAnselme, F., Moubarak, G., Savouré, A., GODIN, B., Borz, B., Drouin‐Garraud, V., & Gay, A. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.06.020 · Cited by 125
Vytopil, M., Benedetti, S., Ricci, E., Galluzzi, G., Russo, A. D., Merlini, L., Boriani, G., Gallina, M., Morandi, L. O., Politano, L., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.12.e132 · Cited by 121 · cited 1×
“In one study, three of five patients with the early and rapidly progressive phenotype became nonambulatory between the ages of 8 and 13 years.(10,89,90) The phenotypic variability seen with LMNA mutations does not appear to be directly associated with the type of mutation, evidenced”
BackgroundNovel and recurrent mutations in lamin A/C in patients with Emery-Dreifuss muscular dystrophy
Brown, C. A., Lanning, R. W., McKinney, K. Q., Salvino, A. R., Cherniske, E., Crowe, C. A., Darras, B. T., Gominak, S., Greenberg, C. R., Grosmann, C., et al. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1463 · Cited by 117 · cited 5×
“17,27-29 In 1999, Bonne et al. mapped the locus for EDMD2 to chromo- some 1q11-q23, and the LMNA gene which lies within that interval was found to be the associated gene.18,30 Mutations in LMNA result in disruption of the lamin A/C (LMNA) proteins, most typically with an autosomal dominant inheritance pattern, leading…”
BackgroundInfluentialEmery–Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies
Bonne, G., & Quijano-Roy, S. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00007-1 · Cited by 109 · cited 1×
“There are still more causative genes yet to be discovered, as over 60% of patients with EDMD do not have detectable mutations in EMD or LMNA, the two most common genes.(24) In 1986, the molecular era began for EDMD when the first locus”
BackgroundCharacterization of Two Isoforms of the Skeletal Muscle LIM Protein 1, SLIM1
Brown, S., McGrath, M. J., Ooms, L. M., Gurung, R., Maimone, M. M., & Mitchell, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27083 · Cited by 103
Zhou, C., Li, C., Zhou, B., Sun, H., Koullourou, V., Holt, I., Puckelwartz, M. J., Warren, D. T., Hayward, R., Lin, Z., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx116 · Cited by 103 · cited 3×
“Only a single case each of primary mutation(s) causing EDMD has been described for SUN1 and SUN2.”
BackgroundAssociation of emerin with nuclear and cytoplasmic actin is regulated in differentiating myoblasts
Lattanzi, G., Cenni, V., Marmiroli, S., Capanni, C., Mattioli, E., Merlini, L., Squarzoni, S., & Maraldi, N. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00415-7 · Cited by 102 · cited 1×
“In the case of LMNA mutations, and the associated effects on LMNA, there also appears to be an effect on myocytes and muscle regeneration, as these proteins are expressed in mature myocytes, skeletal muscle stem cells, and satellite cells.(70) Thus, mutations in LMNA can lead to impaired muscle regeneration, and ultim…”
BackgroundThe LINC complex and human disease
Meinke, P., Nguyen, T. D., & Wehnert, M. S. (2011) · Biochemical Society Transactions · doi:10.1042/bst20110658 · Cited by 102 · cited 4×
“Only a single case each of primary mutation(s) causing EDMD has been described for SUN1 and SUN2.”
BackgroundInfluentialWydner, K. L., McNeil, J. A., Lin, F., Worman, H. J., & Lawrence, J. B. (1996) · Genomics · doi:10.1006/geno.1996.0146 · Cited by 99
Bonne, G., Yaou, R. B., Béroud, C., Boriani, G., Brown, S., de Visser, M., Duboc, D., Ellis, J. A., Hausmanowa-Petrusewicz, I., Lattanzi, G., et al. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00063-4 · Cited by 99
The prevalence of inherited neuromuscular disease in Northern Ireland
Hughes, M. I., Hicks, E. M., Nevin, N. C., & Patterson, V. (1996) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)00017-4 · Cited by 95
Wheeler, M., Davies, J. D., Zhang, Q., Emerson, L. J., Hunt, J. S., Shanahan, C. M., & Ellis, J. A. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.025 · Cited by 94
Cowling, B. S., Cottle, D. L., Wilding, B. R., D’Arcy, C. E., Mitchell, C. A., & McGrath, M. J. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.01.001 · Cited by 84 · cited 1×
“myopathy, X-linked myopathy with postural muscle atrophy, and hypertrophic cardiomyopathy.(95,96)”
BackgroundCardiac involvement in Emery Dreifuss muscular dystrophy: a case series
Buckley, A. E., Dean, J., & Mahy, I. R. (1999) · Heart · doi:10.1136/hrt.82.1.105 · Cited by 81
Emerin and the Nuclear Lamina in Muscle and Cardiac Disease
Holaska, J. M. (2008) · Circulation Research · doi:10.1161/circresaha.108.172197 · Cited by 81 · cited 3×
“35,67 An exception is FHL1, a protein encoded by the gene of the same name, which localizes to the sarcomere and the sarcolemma; at the former, it contributes to sarcomere assembly.38,39 Mutant forms of emerin show diminished transport to the inner nuclear membrane,68 and have been associated with decreased nuclear in…”
BackgroundEffect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo
Holt, I., Östlund, C., Stewart, C. L., Mân, N. T., Worman, H. J., & Morris, G. E. (2003) · Journal of Cell Science · doi:10.1242/jcs.00599 · Cited by 74
LMNA -associated myopathies: The Italian experience in a large cohort of patients
Maggi, L., D’Amico, A., Pini, A., Sivo, S., Pane, M., Ricci, G., Vercelli, L., D′Ambrosio, P., Travaglini, L., Sala, S., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000934 · Cited by 73 · cited 1×
“Missense mutations are frequently seen in EDMD2 as opposed to other laminopathies.(31) De novo mutations are common (76% in one study).”
BackgroundNesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells
Kandert, S., Lüke, Y., Kleinhenz, T., Neumann, S., Lu, W., Jaeger, V. M., Munck, M., Wehnert, M., Müller, C. R., Zhou, Z., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm255 · Cited by 72 · cited 1×
“Nesprins contribute to nuclear envelope localization and structural integrity.(36,37) In 2009, a fifth gene, FHL1, located on Xq26.”
BackgroundMultiple roles for emerin: Implications for Emery‐Dreifuss muscular dystrophy
Holaska, J. M., & Wilson, K. L. (2006) · The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology · doi:10.1002/ar.a.20334 · Cited by 72
Clinical aspects of Emery-Dreifuss muscular dystrophy
Madej‐Pilarczyk, A. (2018) · Nucleus · doi:10.1080/19491034.2018.1462635 · Cited by 71
Vignier, N., Chatzifrangkeskou, M., Rodríguez, B. M., Mericskay, M., Mougenot, N., Wahbi, K., Bonne, G., & Muchir, A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy278 · Cited by 67 · cited 1×
“dinucleotide (NAD+), improved cardiac function in a laminopathy mouse model.(144) Among these candidates, ARRY-371797 is currently under investigation in a Phase 3 study focusing on patients with cardiomyopathy caused by LMNA mutations.”
BackgroundNuclear protein import is reduced in cells expressing nuclear envelopathy-causing lamin A mutants
Busch, A., Kiel, T., Heupel, W.-M., Wehnert, M. S., & Hubner, S. E. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.05.003 · Cited by 65 · cited 1×
“A potential unifying disease mechanism may be loss of protein importation into the nucleus.(50,51) The nuclear envelope is composed of an inner and outer”
BackgroundPrevalence of Neuromuscular Diseases in Chinese Children: A Study in Southern China
Chung, B. H., Wong, V. C. N., & Ip, P. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180030201 · Cited by 58 · cited 2×
“examined four diverse populations representing Northern Ireland,(6) Northern England,(7) Assuit, Egypt,(8) and Hong Kong.(9) Sporadic mutations are believed to be infrequent for EMD, but are becoming increasingly recognized for LMNA.”
Backgroundde Cid, R., Yaou, R. B., Roudaut, C., Charton, K., Baulande, S., Leturcq, F., Romero, N. B., Malfatti, E., Beuvin, M., Vihola, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002200 · Cited by 56
Astejada, M., Goto, K., Nagano, A., Ura, S., Noguchi, S., Nonaka, I., Nishino, I., & Hayashi, Y. K. (2007) · Europe PMC (PubMed Central) · Cited by 55
Importance and challenge of making an early diagnosis in LMNA -related muscular dystrophy
Menezes, M. P., Waddell, L. B., Evesson, F. J., Cooper, S. T., Webster, R., Jones, K., Mowat, D. R., Kiernan, M. C., Johnston, H. M., Corbett, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318250d839 · Cited by 47
Jiménez‐Escrig, A., Gobernado, I., García-Villanueva, M., & Sánchez-Herranz, A. (2011) · Muscle & Nerve · doi:10.1002/mus.22324 · Cited by 47 · cited 1×
“However, four members of a family with EDMD3 did in fact develop cardiac sequelae, including supraventricular and/or ventricular arrhythmias.(92)”
BackgroundThomas, N. S., Williams, H., Elsas, L. J., Hopkins, L. C., Sarfarazi, M., & Harper, P. S. (1986) · Journal of Medical Genetics · doi:10.1136/jmg.23.6.596 · Cited by 46 · cited 1×
“for this disease was mapped to the Xq27-28 region by Thomas and colleagues.(25) The gene was subsequently cloned and assigned the symbol EMD.”
MethodScharner, J., Figeac, N., Ellis, J. A., & Zammit, P. S. (2015) · Gene Therapy · doi:10.1038/gt.2015.8 · Cited by 45
Smith, G. C., Kinali, M., Prasad, S. K., Bonne, G., Muntoni, F., Pennell, D. J., & Nihoyannopoulos, P. (2006) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640600723862 · Cited by 38 · cited 3×
“Cardiac MRI is particularly useful for the detection of cardiac fibrosis; however, many children will require sedation for such studies.(124)”
BackgroundInfluentialPfaff, J., Rivera‐Monroy, J. E., Jamieson, C., Rajanala, K., Vilardi, F., Schwappach, B., & Kehlenbach, R. H. (2015) · Journal of Cell Science · doi:10.1242/jcs.179333 · Cited by 36
Emerin plays a crucial role in nuclear invagination and in the nuclear calcium transient
Shimojima, M., Yuasa, S., Motoda, C., Yozu, G., Nagai, T., Ito, S., Lachmann, M., Kashimura, S., Takei, M., Kusumoto, D., et al. (2017) · Scientific Reports · doi:10.1038/srep44312 · Cited by 36 · cited 1×
“Mutant forms of emerin show diminished transport to the inner nuclear membrane,(68) and have been associated with decreased nuclear invagination and abnormalities in nuclear Ca transients.(69)”
BackgroundA novel SYNE1 gene mutation in a Chinese family of Emery-Dreifuss muscular dystrophy-like
Chen, Z., Ren, Z., Mei, W., Ma, Q., Shi, Y., Zhang, Y., Li, S., Li, X., & Zhang, J. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0424-5 · Cited by 33 · cited 1×
“Within this spectrum, most patients with EDMD4, associated with SYNE1 mutations, manifest with gradually progressive muscle weakness and atrophy, joint contractures, and no significant cardiac involvement.(93,94) EDMD5, on the other hand, classically presents with muscle weakness and cardiac features (eg, arrhythmia,…”
BackgroundContribution of SUN1 Mutations to the Pathomechanism in Muscular Dystrophies
Li, P., Meinke, P., Hương, L. T. T., Wehnert, M. S., & Noegel, A. A. (2013) · Human Mutation · doi:10.1002/humu.22504 · Cited by 31 · cited 2×
“SUN1, encoded by a gene of the same name, was originally studied as a protein that accumulates in the setting of LMNA mutations,(41) but more recently variants in SUN1 were reported to worsen cellular defects in the setting of primary EDMD mutations.(42) In 2014, a report showed both primary mutations and modifying va…”
BackgroundAtypical motor unit potentials in Emery–Dreifuss muscular dystrophy (EDMD)
Rowińska-Marcińska, K., Szmidt-Sałkowska, E., Fidziańska, A., Zalewska, E., Dorobek, M., Karwanska, A., & Hausmanowa-Petrusewicz, I. (2005) · Clinical Neurophysiology · doi:10.1016/j.clinph.2005.01.017 · Cited by 29
Arrhythmia-related workup in hereditary myopathies
Finsterer, J., Stöllberger, C., & Keller, H. (2012) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2012.02.003 · Cited by 27 · cited 2×
“Another source recommends ICD placement as soon as ventricular tachycardia is detected.(129) 11.”
BackgroundSommerville, R. B., Vincenti, M. G., Winborn, K., Casey, A., Stitziel, N. O., Connolly, A. M., & Mann, D. L. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.06.005 · Cited by 25 · cited 1×
“All EDMD patients should have thorough cardiac evaluations at diagnosis, including a physical examination, electrocardiogram (ECG), echocardiogram, and Holter monitor.(116,117) For LMNA mutations in particular, the high penetrance, especially with regard to cardiac symptoms (nearly complete by the age of 60 years), an…”
BackgroundWu, W., Chordia, M. D., Hart, B. P., Kumarasinghe, E. S., Ji, M. K., Bhargava, A., Lawlor, M. W., Shin, J., Sera, F., Homma, S., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.12.014 · Cited by 21
Park, J., Oh, H. M., Park, H. J., Cho, A., Lee, D., Jang, J., & Jang, D. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.947 · Cited by 19 · cited 1×
“Most disease-focused genetic tests are currently designed as targeted sequence capture panels, based on next generation sequencing technology.(113,114) To capture”
BackgroundLin, H., Liu, X., Zhang, W., Liu, J., Zuo, Y., Xiao, J., Zhu, Y., Yuan, Y., & Wang, Z.-X. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.233957 · Cited by 19 · cited 1×
“Only one of these patients showed a similar pattern of fatty infiltration in the calf muscles.(105)”
BackgroundMuscle diseases with prominent joint contractures: Main entities and diagnostic strategy
Eymard, B., Ferreiro, A., Yaou, R. B., & Stojkovic, T. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.005 · Cited by 19 · cited 1×
“such as Ullrich congenital muscular dystrophy and Bethlem myopathy may present with early contractures, as may SEPN1-related myopathy.(13) Numerous underlying diseases have been found to”
BackgroundRodríguez, B. M., Khouzami, L., Decostre, V., Varnous, S., Pekovic‐Vaughan, V., Hutchison, C. J., Pecker, F., Bonne, G., & Muchir, A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy243 · Cited by 18 · cited 1×
“Alleviation of oxidative stress in laminopathies has been achieved with N-acetyl cysteine.(143) Lastly, nicotinamide riboside, a natural precursor of nicotinamide adenine”
BackgroundNesprin-2 mediated nuclear trafficking and its clinical implications
Kelkar, P., Walter, A. M., Papadopoulos, S., Mroß, C., Munck, M., Peche, V. S., & Noegel, A. A. (2015) · Nucleus · doi:10.1080/19491034.2015.1128608 · Cited by 17 · cited 1×
“A potential unifying disease mechanism may be loss of protein importation into the nucleus.(50,51) The nuclear envelope is composed of an inner and outer”
BackgroundThanh, P. L., Meinke, P., Korfali, N., Sršeň, V., Robson, M. I., Wehnert, M. S., Schoser, B. G. H., Sewry, C. A., & Schirmer, E. C. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.12.003 · Cited by 14
Khan (2000) · doi:10.1002/1531-8249(200008)48:2 · cited 13×
“De novo mutations are common (76% in one study).(10) Autosomal recessive mutations in LMNA have also been associated with EDMD, and these have been assigned to the subtype EDMD3.”
BackgroundInfluential
Cited by
LINCing Nuclear Mechanobiology With Skeletal Muscle Mass and Function
van Ingen, M. J. A., & Kirby, T. J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.690577 · Cited by 26
Metadata
- Authors
- Heller, S. A., Shih, R., Kalra, R., & Kang, P. B.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2019-12-28
- Volume
- 61
- Issue
- 4
- Pages
- 436-448
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2994835401
- Cited by
- 164
- References
- 116
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.